We are committed to developing transformational biologic medicines to serve patients with debilitating diseases
Press Releases
Press Releases
Applied Molecular Transport to Present at SVB Leerink 10th Annual Global Healthcare Conference
Feb 17, 2021
SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the SVB
Applied Molecular Transport Appoints Douglas Rich as Chief Technical Officer
Jan 19, 2021
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has appointed Douglas Rich as Chief Technical Officer. In his new role, Douglas will assume leadership